Ferrer Group Inc. Company Profile

16:19 EDT 1st September 2015 | BioPortfolio

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the fields of medicine and pharmacology, and maintain direct contact with health professionals, patients and the general public.

Location

Edifici L'illaDiagonal, 549 5a planta
Barcelona
E-08029
Spain

Contact

Phone: 34 93 600 37 00
Fax: 34 93 490 70 78
Email: medicaldepartment@ferrergrupo.com


News Articles [172 Associated News Articles listed on BioPortfolio]

Cipher Pharmaceuticals Announces Successful Completion of Second Phase 3 Study for Ozenoxacin

Cipher Pharmaceuticals Inc. announced that Ferrer International SA ("Ferrer") successfully completed the second phase 3 clinical trial for Ozenoxacin, a topical treatment for adult and paediatric pati...

Cipher Pharmaceuticals Announces Successful Completion of Second Phase III for Ozenoxacin

MISSISSAUGA, ON, July 30, 2015 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Ferrer International SA ("Ferrer") successfully completed the...

Ferrer successfully completes second phase III clinical trial in adult and paediatric patients with impetigo for antibacterial Ozenoxacin

Ferrer announces that it has successfully completed a second phase III clinical trial in adult and paediatric patients aged two months and older with impetigo, utilizing Ozenoxacin 1% cream as a topic...

Ferrer initiates Phase IIa clinical study of Lorediplon in patients with insomnia

The first patient has been recruited into a Phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in insomnia... The post Ferrer initiates Phase IIa clinical stu...

BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations

One of the nation’s leading innovative specialty pharmacies, BioPlus, continues to grow by promoting Sharon Ferrer as Vice President of Pharmaceutical Relations. Altamonte Springs, FL (PRWEB) March ...

TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors

By deciphering the transcriptional network of human embryonic pancreatic progenitors, Ferrer and colleagues identify the Hippo-responsive transcription factor TEAD1 as a regulator of the pancreatic pr...

Alexza Pharmaceuticals (ALXA) - Still awaiting an inflection point in Adasuve growth

Edison Investment Research - Pharmaceutical & Healthcare - Alexza Pharmaceuticals: Recent Adasuve orders from Alexza’s commercial partners, Teva and Ferrer, were below company expectations and r...

SHL Group introduces new Corporate Website

Published date:  10/04/2015 Summary:  SHL Group launches brand new corporate websi...

PubMed Articles [2412 Associated PubMed Articles listed on BioPortfolio]

Enzymatic Debridement in Necrotizing Pancreatitis.

Multiple organ failure and pancreatic necrosis are the factors that determine prognosis in acute pancreatitis attacks. We investigated the effects of collagenase on the debridement of experimental pan...

When talking makes you feel like a group: The emergence of group-based emotions.

Group-based emotions are emotional reactions to group concerns and have been shown to emerge when people appraise events while endorsing a specific social identity. Here we investigate whether discuss...

Commentary on "Toward Understanding and Treating Violence in America: Some Contributions From Group Dynamic and Group Therapy Perspectives".

Commentary on "Toward Understanding and Treating Violence in America: Some Contributions From Group Dynamic and Group Therapy Perspectives".

Degenerative changes in the interspinous ligament.

Objective: The aim of this study was to investigate the imaging assessment of interspinous ligament degeneration (ISLD) in patients with or without low back pain (LBP). Methods: Sixty patients with LB...

Clinical Trials [1736 Associated Clinical Trials listed on BioPortfolio]

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Early Group Based Parental Support Within Child Health Service - Group Leadership

All parents in Sweden are offered group based parental support within Child Health Service (CHS) but only 40% participate. Nurses feel insecure in their group leadership and express a need...

Sublingual Microcirculation Data of Patients With Systemic Diseases

This is an observational clinical study, patients with systemic diseases will be enrolled according to the inclusion and exclusion criteria. 360 patients will received the examination of s...

Psychological Prevention of Internalizing Disorders

The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcom...

Companies [1487 Associated Companies listed on BioPortfolio]

Ferrer Group Inc.

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the...

Ferrer Freeman & Company, LLC

Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focuses exclusively on growth capital investments in the healthcare industry. Since its founding i...

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for ...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Ferrer Group Inc." on BioPortfolio

We have published hundreds of Ferrer Group Inc. news stories on BioPortfolio along with dozens of Ferrer Group Inc. Clinical Trials and PubMed Articles about Ferrer Group Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ferrer Group Inc. Companies in our database. You can also find out about relevant Ferrer Group Inc. Drugs and Medications on this site too.


Advertisement
 

Relevant Topic

Nutrition
Latest News Clinical Trials Research Drugs Reports Corporate
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record